Abstract:Magnetic Resonance Imaging(MRI)is a powerful method for clinical diagnosis and therapy due to the distinguishing characteristics of providing high-quality three-dimensional images of soft tissue without the need for harmful ionizing radiation.Complexes of gadolinium(Ⅲ)have proven to be especially effective M RI contrast agents,as it is estimated that they are needed for over 30% of the patients to accelerate relaxation rate of in vivo water protons,thus enhancing the contrast of different biological tissues and definition between normal tissues and diseased parts.For more sensitive small-molecule gadolinium-based M RI contrast agents,one essential requirement is to increase the hydration number q, which enhances the gadolinium's relaxivity.However,with the concern of chronic kidney disease(CKD) and nephrogenic systemic fibrosis(NSF),competition between strong chelate stability and free water coordination sites has increasingly become a challenge to M RI enhancement agent design.A highly stable N-oxide-DTPA-bisamide-based Gd(Ⅲ)complex with 3 coordinated water molecules is synthesized.The general methods such as 1 H-NMR,13C-NMR and ESI-MS spectroscopy are used to characterize the structures of the ligand and the complex.T he hydration number determined by the fluorescence lifetime of its Europium(Ⅲ)analogue is 3.M RI measurement show s much higher relaxivity value(16.39 mM -1·s-1) than commercial contrast agents.By fitting the potentiometric data with HYPERQUAD program,the formation constants of the Gd(Ⅲ)complex are calculated and demonstrated a superior stability over Gd-DTPA-BMA(Omniscan?).Meanwhile,in vivo imaging shows good imaging quality and cell tests reveal low cytotoxicity of the complexes,which indicate its great potential for future clinical applications.

Gadolinium-based Contrast Agents Built of DO3A-pyridine Scaffold: Precisely Tuning Carboxylate Group for Enhanced Magnetic Resonance Imaging

Gd3+-1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic-2-hydroxypropyl-β-cyclodextrin/Pluronic Polyrotaxane As a Long Circulating High Relaxivity MRI Contrast Agent

Geometrical Confinement of Gadolinium Oxide Nanoparticles in Poly(ethylene Glycol)/arginylglycylaspartic Acid-Modified Mesoporous Carbon Nanospheres As an Enhanced T1 Magnetic Resonance Imaging Contrast Agent.

Gadolinium‐based Contrast Agents for Magnetic Resonance Cancer Imaging

Synthesis of a Highly Stable Gadolinium Based MRI Contrast Agent

Design and synthesis of chiral DOTA-based MRI contrast agents with remarkable relaxivities

Facile Preparation of a New Gadofullerene-Based Magnetic Resonance Imaging Contrast Agent with High 1H Relaxivity

Gadolinium Complexes of Macrocyclic Diethylenetriamine-N-oxide Pentaacetic Acid-Bisamide As Highly Stable MRI Contrast Agents with High Relaxivity.

Gadolinium(III)-based Polymeric Magnetic Resonance Imaging Agents for Tumor Imaging

Formation of Nanosized Gd(III) Coordination Networks with Tripodal Amine-N-oxide Type Ligand Through Microemulsions to Achieve High Relaxivity and Exceptional Stability for MRI Applications

Facile Synthesis of Weakly Ferromagnetic Organogadolinium Macrochelates-Based T1-Weighted Magnetic Resonance Imaging Contrast Agents

Gadolinium(III) Chelated Conjugated Polymer As a Potential MRI Contrast Agent

Rational Design of Gd-DOTA-Type Contrast Agents for Hepatobiliary Magnetic Resonance Imaging

A new biodegradable and biocompatible gadolinium (III) -polymer for liver magnetic resonance imaging contrast agent

Chiral Gd-DOTA as a Versatile Platform for Hepatobiliary and Tumor Targeting MRI Contrast Agents

Gadolinium(III) Complex-Backboned Branched Polymers As Imaging Probes for Contrast-Enhanced Magnetic Resonance Angiography

Synthesis and preliminary evaluation of gadolinium complexes containing sulfonamide groups as potential MRI contrast agents

Synthesis and evaluation of Gd-DTPA-labeled arabinogalactans as potential MRI contrast agents

Gadolinium-labeled peptide dendrimers with controlled structures as potential magnetic resonance imaging contrast agents.

Preparation of MRI-visible Gadolinium Methacrylate Nanoparticles with Low Cytotoxicity and High Magnetic Relaxivity

Synthesis and Properties of a Biodegradable Dendritic Magnetic Resonance Imaging Contrast Agent